Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

121 results about "ORAL DRYNESS" patented technology

"Sicca" simply means dryness. Sicca syndrome is not a specific condition, and there are varying definitions, but the term can describe oral and eye dryness that is not caused by autoimmune diseases (e.g., Sjögren syndrome).

Pulsatile release compositions of milnacipran

InactiveUS20060003004A1Minimize exposureReduces milnacipran gastrointestinal side effectCapsule deliveryCoatingsPalpitationsPanic
A once-a-day oral milnacipran pulsatile release composition has been developed that releases the drug in spaced apart “pulses”. The dosage forms are comprised of first, second and optional third dosage units, with each dosage unit having a different drug release profile. This dosage form provides in vivo drug plasma levels characterized by Cmax below 3000 ng / ml, preferably below 2000 ng / ml, and most preferably below 1000 ng / ml. The composition provides pulsatile release of milnacipran to produce a therapeutic effect over approximately 24 hours, when administered to a patient in need, resulting in diminished incidence or decreased intensity of common milnacipran side effects such as sleep disturbance, nausea, vomiting, headache, tremulousness, anxiety, panic attacks, palpitations, urinary retention, orthostatic hypotension, diaphoresis, chest pain, rash, weight gain, back pain, constipation, vertigo, increased sweating, agitation, hot flushes, tremors, fatigue, somnolence, dyspepsia, dysoria, nervousness, dry mouth, abdominal pain, irritability, and insomnia.
Owner:COLLEGIUM PHARMA INC

Combination drug therapy using orally dissolving film or orally disintegrating tablet dosage forms to treat dry mouth ailments

A combination drug therapy can be administered to patients to treat xerostomia or dry mouth or Sjogren's syndrome in the form of orally dissolving film or orally disintegrating tablets. Some of the drugs could be synthetic origin and some drugs are obtained from natural sources.
Owner:JOSHI HEMANT NARAHAR

Hangover remedy and alcohol abatement composition

An anti-intoxication composition and method of making and using are provided for treating and preventing drinker's remorse and other toxic effects of excessive alcohol consumption by humans. The anti-intoxication composition is an acidic mixture containing sweeteners, flavoring agents, food additives and a processed mixture of metallic salts, sulfuric acid, ammonium sulfate and water. When the anti-intoxication composition is ingested, it promotes the beneficial metabolism of alcohol, primarily ethanol, in the body. The beneficial metabolism results in the conversion of alcohol to amino acids and eliminates the toxic reactions of a hangover, including, but not limited to, a pounding headache, nausea, dry mouth, shaking hands, hypersensitivity to bright lights and sounds.
Owner:TASKER PRODS IP HLDG CORP

Preventive/remedy for urinary disturbance

InactiveUS20070021391A1Enhances elimination function of bladderReduce collection functionCompound screeningBiocideSide effectCholinesterase inhibition
It is intended to provide a preventive / remedy for urinary disturbance containing a compound, which shows an acetylcholine esterase inhibitory activity but substantially has no butyrylcholine esterase inhibitory activity, showing no side effect and being safe and efficacious without inhibiting the urine collection function; a preventive / remedy for dry mouth induced by the administration of a remedy for urinary disturbance and a preventive or remedy for hyperactive bladder not accompanied by dry mouth; and a method of screening a substance preventing / treating urinary disturbance without inhibiting the urine collection function characterized by comprising measuring and comparing the acetylcholine esterase inhibitory activity and the butyrylcholine esterase inhibitory activity of a test compound.
Owner:TAKEDA PHARMA CO LTD

Traditional Chinese medicine preparation for treating type II diabetes and preparation method thereof

The invention discloses a traditional Chinese medicine preparation for treating type-2 diabetes, and the traditional Chinese medicine preparation is prepared by the following raw materials according to the mixture ratio by weight: 10-20 parts of radix salviae albae, 10-15 parts of membranous milkvetch root, 10-15 parts of dried rehmannia root, 6-12 parts of barbary wolfberry fruit, 10-15 parts of Mongolian snakegourd root, 5-10 parts of common anemarrhena rhizome, 5-10 parts of kudzuvine root and 1-2 parts of liquoric root. In addition to a certain hypoglycemic effect, the traditional Chinese medicine preparation can significantly improve the type-2 diabetes, in particular to the symptoms of dry mouth and throat, malaise, fatigue, soreness and weakness of waist and knees, burning heat, insomnia, blurred vision, dizziness, heart palpitations, limb numbness and pain, and the like of patients with deficiency of both qi and yin and the blood stasis type diabetes. The greatest feature of the traditional Chinese medicine preparation to be different from the existing technologies is that the radix salviae albae which is the special local herbal medicine in Shandong is firstly applied in the formula for treating the diabetes, thereby effectively improving the clinical treatment effect.
Owner:郭业新

Medical biological blood sugar level reducing oral liquid and preparation method thereof

The invention relates to a medical biological oral liquid, in particular to a medical biological blood sugar level reducing oral liquid and a preparation method thereof. The oral liquid consists of a bitter gourd extracting solution, a rhizoma polygonati extracting solution, a Chinese yam extracting solution, a rhizoma anemarrhenae extracting solution, a radix polygonati officinalis extracting solution, a radix ophiopogonis extracting solution, a radix rehmanniae extracting solution, a radices trichosanthis extracting solution, a fructus lycii extracting solution, a folium mori extracting solution, a radix puerariae extracting solution, a poria with hostwood extracting solution, a liquorice extracting solution, a platycodon grandiflorum extracting solution, a Rhodiola rosea extracting solution, a rhizoma atractylodis macrocephalae extracting solution, a burdock extracting solution, a schisandra chinensis extracting solution and deionized water. All raw materials are mutually matched, advantages are exerted and disadvantages are overcome, the oral liquid is used for treating symptoms such as weakness of the spleen and the stomach, body fatigue and weakness, dry mouth and reduced appetite, deficiency syndrome of the lung and cough caused by dryness, essence and blood deficiency, internal thermal and consumptive thirst. The oral liquid is capable of clearing heat-fire, helping produce saliva and slake thirst, diminishing swelling and discharging pus, and treating pyreticosis, polydipsia, lung heat, dry cough, internal heat and consumptive thirst, and the oral liquid particularly has a good curative effect for treating diabetes and reducing blood glucose.
Owner:广西达庆生物科技有限公司

Mouthwash composition

A non-alcohol mouthwash composition includes: a sweetener, a dispersing agent, a surfactant, an antimicrobial agent, a calcium ion source including calcium lactate, a phosphate ion source including monobasic sodium phosphate, a flavoring agent, a fluoride source, and water. The non-alcohol mouthwash composition includes about 0.001 weight percent of the calcium lactate and about 0.10 weight percent of the monobasic sodium phosphate, based on total weight percent of the non-alcohol mouthwash composition, and the composition has a pH greater than about 5.5. According to embodiments, the non-alcohol mouthwash composition exhibits desirable advantages of being alcohol free, being sodium laural sulfate free, being gluten free, and being substantially 100% natural, as well as alleviating Xerostomia (dry mouth) by stimulating salivary flow, combatting enamel erosion by providing a means of remineralization, providing anticariogenic activity by acting as an antimicrobial agent, and / or providing anti-inflammatory activity, among other benefits.
Owner:FANTARELLA & HAREWOOD LLC

Confectionery products for the treatment of dry mouth

InactiveUS20060263414A1Preventing and reducing and alleviating symptomBiocideDigestive systemThroatDrying mouth
The present invention relates to orally ingestible compositions also referred to herein as confectionery products for delivery of saliva stimulating and / or saliva substitute to the mouth and throat. The orally ingestible compositions include a core and a shell surrounding the core so that the core is generally centrally or substantially centrally positioned therein. The composition of the core and shell make the confection uniquely suited for the targeted delivery of the saliva stimulating or saliva substitute to the mouth and throat.
Owner:MCNEIL PPC INC

Oral composition and method of forming and using same

An oral composition for the treatment of dry mouth symptoms and other conditions, a method of forming the oral composition, and a method of using the oral composition are disclosed. The oral composition includes a plurality of enzymes to prevent formation of and / or facilitate the break up of biofilm in an oral cavity and a metal ion management system to inhibit growth of gram negative bacteria.
Owner:DR FRESH LLC

Compound combination medicament for treating COPD, preparation method and application thereof

The invention discloses a compound combination medicament for treating COPD, a preparation method and an application thereof. The compound combination medicament comprises the following components by weight: 10 to 60 parts of codonopsis pilosula, 20 to 50 parts of rhubarb, 40 to 100 parts of root of scutellaria, 15 to 60 parts of lapis chlorite (fried), 10 to 60 parts of bighead atractylodes rhizome (fried), 20 to 60 parts of poria cocos, 10 to 100 parts of pinellia, 5 to 70 parts of reddish orange, 15 to 120 parts of ephedra, 10 to 110 parts of almond, 10 to 150 parts of agilawood, 10 to 60 parts of liguisticum chuanxiong, 5 to 160 parts of ginger, and 40 to 200 parts of earthworm. The compound combination medicament provided in the invention is used for treating the COPD at the attack stage and is mainly used for treating spleen-deficiency and lung-heat COPD, wherein the symptoms of the spleen-deficiency and lung-heat COPD are cough, asthma, expectoration with yellow or white mucous sputum, dry excrement, dry mouth, abdominal fullness and distension, flat tongue with tooth mark on it, thin and yellow tongue coating, and wiry and slippery pulse. The compound combination medicament provided in the invention is used for treating the COPD at the attack stage and is mainly used for treating spleen-deficiency and lung-heat COPD, wherein the symptoms of the spleen-deficiency and lung-heat COPD are cough, asthma, expectoration with yellow or white mucous sputum, dry excrement, dry mouth, abdominal fullness and distension, flat tongue with tooth mark on it, thin and yellow tongue coating, and wiry and slippery pulse. The compound combination medicament has advantages of good curative effectiveness, short treating course, thorough treatment, no side effects and the like. Moreover, the compound combination medicament, which is made in a form of mixture, tablet, capsule, pellet, is easy to carry and to take.
Owner:JIANGSU PROVINCIAL HOSPITAL OF TCM

Compound thrombus-clearing Chinese medicinal preparation and preparation method thereof

The invention discloses a compound thrombus-clearing Chinese medicinal preparation and a preparation method thereof. The compound thrombus-clearing Chinese medicinal preparation comprises active ingredients and / or pharmaceutically acceptable additives which are prepared from the following raw materials: 200 to 1,000 grams of sanchi, 50 to 400 grams of astragalus, 40 to 20 grams of radix salviae miltiorrhizae, 60 to 400 grams of figwort root, and 100 to 800 grams of sanchi decoction dreg powder. The Chinese medicinal preparation has the functions of quickening the blood and transforming stasis, expanding blood vessels, increasing blood flow volume, improving blood circulation and microcirculation and tonifying qi and yin and is mainly used for treating the symptoms of retinal vein occlusion caused by blood stasis and qi and yin deficiency, such as blurred vision or paropsis, eyeground blood stasis, fatigued spirit and lack of strength, dry throat and dry mouth. The Chinese medicinal preparation is also applicable to people with the symptoms of stable exertional angina caused by blood stasis and qi and yin deficiency, such as chest distress, chest pain, palptation, flusteredness, shortness of breath, lack of strength, heart vexation and dry mouth.
Owner:GUANGDONG ZHONGSHENG PHARMA

Toothpaste suitable for diabetes patients

ActiveCN102113986ASolve the problem of small amount of secretion stimulationCosmetic preparationsToilet preparationsMouth careToothpaste
The invention discloses toothpaste suitable for diabetes patients. A paste composition of the toothpaste contains 4-12 wt% of body fluid generating components, wherein the body fluid generating components are Acmella uliginosa extracts, Ophiopogon japonicus extracts and Radix Puerariae extracts; the weight percentage of spilanthol in the paste composition of the toothpaste is more than or equal to 0.01%; the weight percentage of Ophiopogon japonicus saponins in the paste composition of the toothpaste is more than or equal to 0.01%; and weight percentage of puerarin in the paste composition of the toothpaste is more than or equal to 0.008%. The toothpaste as oral health care product has the functions of promoting salivary secretion, relieving dryness of the oral cavity and removing bad breath, and can effectively relieve oral and dental disorders of diabetes patients.
Owner:LIUZHOU LIANGMIANZHEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products